InnoStar
- CMO, CRO
- Biotech or pharma, therapeutic R&D
InnoStar is a premier preclinical and clinical-stage Contract Research Organization (CRO), offering end-to-end drug development services from discovery to regulatory submission. Founded in 2010, InnoStar supports a wide range of therapeutics—including small molecules, biologics, and cell and gene therapies—across facilities in Shanghai, Nantong, Shenzhen, Huangshan, and San Francisco. With over 1,200 staff and 60,000+ square meters of lab space, the company has supported 900+ global clients. InnoStar holds certifications from the FDA, OECD, NMPA, and AAALAC, ensuring compliance with international standards.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}